About Mosaic Biosciences
Mosaic Biosciences is a company based in Boulder (United States) founded in 2009.. Mosaic Biosciences has raised $14.7 million across 4 funding rounds from investors including Colorado Office of Economic Development and International Trade, Telegraph Hill Partners and Morgenthaler. Mosaic Biosciences offers products and services including Antibody Therapeutics Platform and Protein Therapeutics Service. Mosaic Biosciences operates in a competitive market with competitors including Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others.
- Headquarter Boulder, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mosaic Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.7 M (USD)
in 4 rounds
-
Latest Funding Round
$11.4 M (USD), Series B
Jun 14, 2022
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mosaic Biosciences
Mosaic Biosciences offers a comprehensive portfolio of products and services, including Antibody Therapeutics Platform and Protein Therapeutics Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Accelerates discovery and optimization of therapeutic antibodies.
Designs and characterizes novel proteins for preclinical candidates.
Unlock access to complete
Funding Insights of Mosaic Biosciences
Mosaic Biosciences has successfully raised a total of $14.7M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $11.4 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $11.4M
-
First Round
First Round
(20 Jul 2011)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2022 | Amount | Series B - Mosaic Biosciences | Valuation | Telegraph Hill Partners |
|
| May, 2021 | Amount | Grant - Mosaic Biosciences | Valuation |
investors |
|
| Feb, 2014 | Amount | Series A - Mosaic Biosciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mosaic Biosciences
Mosaic Biosciences has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Colorado Office of Economic Development and International Trade, Telegraph Hill Partners and Morgenthaler. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science, medical device and healthcare companies
|
Founded Year | Domain | Location | |
|
Venture capital and private equity investment firm
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mosaic Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mosaic Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mosaic Biosciences Comparisons
Competitors of Mosaic Biosciences
Mosaic Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ilya Pharma, QBiotics, MediWound, Resolution Therapeutics and SanuWave, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biological drugs for skin and mucosa wound treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small molecules from plant extracts are developed for medical applications.
|
|
| domain | founded_year | HQ Location |
Enzymatic therapies for tissue repair and regeneration are developed.
|
|
| domain | founded_year | HQ Location |
Macrophage cell therapies are developed for inflammatory and liver diseases.
|
|
| domain | founded_year | HQ Location |
Noninvasive devices and biologics for wound healing are developed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for infectious disease
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mosaic Biosciences
Frequently Asked Questions about Mosaic Biosciences
When was Mosaic Biosciences founded?
Mosaic Biosciences was founded in 2009 and raised its 1st funding round 2 years after it was founded.
Where is Mosaic Biosciences located?
Mosaic Biosciences is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Who is the current CEO of Mosaic Biosciences?
Marty Stanton is the current CEO of Mosaic Biosciences.
Is Mosaic Biosciences a funded company?
Mosaic Biosciences is a funded company, having raised a total of $14.7M across 4 funding rounds to date. The company's 1st funding round was a Series A of $2.27M, raised on Jul 20, 2011.
What does Mosaic Biosciences do?
Mosaic Biosciences was founded in 2009 in Boulder, United States, focusing on biotechnology for tissue regeneration. Proprietary technology is utilized to create synthetic extracellular matrices and three-dimensional scaffolds. These materials are engineered with biophysical and biochemical properties to aid applications such as wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. Operations center on advancing this platform for medical uses.
Who are the top competitors of Mosaic Biosciences?
Mosaic Biosciences's top competitors include Ilya Pharma, SanuWave and QBiotics.
What products or services does Mosaic Biosciences offer?
Mosaic Biosciences offers Antibody Therapeutics Platform and Protein Therapeutics Service.
Who are Mosaic Biosciences's investors?
Mosaic Biosciences has 5 investors. Key investors include Colorado Office of Economic Development and International Trade, Telegraph Hill Partners, Morgenthaler, Healthcare Ventures, and High Country Ventures.